HGF/c-Met signaling deficits have been documented in schizophrenic brain tissue, making this the most mechanistically specific target
Ongoing research continually refines understanding of effectiveness across different patient groups
Clinical approach We suggest following a non-judgemental approach in response to peptide use disclosure or inquiry (Box 1)
Active Ingredient BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg Strength Tier Research-grade only Time to Results Not applicable (research use) Sun Sensitivity Not applicable research peptide Regulatory Status Research use only not for human consumption Cycling / Off Period Per study protocol not for human cycling Best For Licensed laboratories and qualified researchers studying tissue-repair signaling, angiogenesis, extracellular matrix remodeling, and copper-peptide effects on collagen
References Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al